Clinical trial
A Multicenter, Prospective, Cohort Study on the Safety and Efficacy of Long-term, High Blood Flow Hemoadsorption Therapy in Patients Undergoing Maintenance Hemodialysis
NCT06574425 is registered in ClinicalTrials.gov with Dongliang Zhang, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Cohort Study on the Safety and Efficacy of Long-term, High Blood Flow Hemoadsorption Therapy in Patients Undergoing Maintenance Hemodialysis
- Lead sponsor
- Dongliang Zhang, MD
- Phase
- Phase 4
- Overall status
- Enrolling by invitation
- Start date
- August 28, 2024
- Completion date
- August 31, 2025
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic kidney diseases, hemodialysis